Literature DB >> 12958204

Regression of upper gastric cancer in mice by FHIT gene delivery.

Hideshi Ishii1, Nicola Zanesi, Andrea Vecchione, Francesco Trapasso, Sai Yendamuri, Manuela Sarti, Raffaele Baffa, Matthew J During, Kay Huebner, Louise Y Y Fong, Carlo M Croce.   

Abstract

Fhit expression is reduced in most cancers, and Fhit replacement by FHIT expression viruses in lung, esophageal, pancreatic, and cervical cancers induces apoptosis in the cancer cells. Mice carrying one or two inactivated Fhit alleles are hypersensitive to development of N-nitrosomethylbenzylamine (NMBA)-induced forestomach tumors. In the present study, we investigated the kinetics and mechanism of tumor reversal and intervention by oral delivery of FHIT expression viruses. Tumor analysis showed that: a) by 37 days post-NMBA, control mice showed approximately 7 tumors and by 84 days approximately 10 tumors/forestomach; b) mice receiving FHIT virus at 2 or 42 days post-NMBA showed significantly reduced tumor burdens; c) Fhit was still expressed at 82 days postinfection; d) control viral infection had no effect on tumor development; and e) reduced Bcl2, increased Bax expression, and increased TUNEL-positive apoptotic nuclei characterized the restored epithelia of FHIT transduced forestomachs. Thus, FHIT viral gene delivery prevents or retards development of carcinogen-induced forestomach tumors and reverses development of established tumors by 60-70% through an apoptotic pathway. This dramatic reduction in tumor burden emphasizes the efficacy of targeting the FHIT apoptotic pathway for tumor eradication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958204     DOI: 10.1096/fj.03-0241fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Gene transfer: Bax to the future for cancer therapy.

Authors:  N R Lemoine; I A McNeish
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.

Authors:  Jin Sun; James Liu; Xueliang Pan; Donald Quimby; Nicola Zanesi; Teresa Druck; Gerd P Pfeifer; Carlo M Croce; Louise Y Fong; Kay Huebner
Journal:  Carcinogenesis       Date:  2010-11-19       Impact factor: 4.944

3.  Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.

Authors:  Xin-Han Zhao; Shan-Zhi Gu; Hong-Gang Tian; Ping Quan; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

4.  Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Authors:  Daniel L Kiss; Catherine E Waters; Iman M Ouda; Joshua C Saldivar; Jenna R Karras; Zaynab A Amin; Seham Mahrous; Teresa Druck; Ralf A Bundschuh; Daniel R Schoenberg; Kay Huebner
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-14       Impact factor: 4.490

5.  Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker.

Authors:  Emma Bragantini; Stefano Barbi; Stefania Beghelli; Patrick S Moore; Giovanni de Manzoni; Franco Roviello; Anna Tomezzoli; Carla Vindigni; Raffaele Baffa; Aldo Scarpa
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-11       Impact factor: 4.553

6.  Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection.

Authors:  Krystyna Stec-Michalska; Slawomir Antoszczyk; Grazyna Klupinska; Barbara Nawrot
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

7.  Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.

Authors:  F Andriani; P Perego; N Carenini; G Sozzi; L Roz
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

Review 8.  Gene therapy for gastric cancer: is it promising?

Authors:  Andreas P Sutter; Henry Fechner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

9.  Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.

Authors:  Ayumi Matsuyama; Takeshi Shiraishi; Francesco Trapasso; Tamotsu Kuroki; Hansjuerg Alder; Masaki Mori; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

10.  Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells.

Authors:  Francesco Trapasso; Flavia Pichiorri; Marco Gaspari; Tiziana Palumbo; Rami I Aqeilan; Eugenio Gaudio; Hiroshi Okumura; Rodolfo Iuliano; Giampiero Di Leva; Muller Fabbri; David E Birk; Cinzia Raso; Kari Green-Church; Luigi G Spagnoli; Salvatore Venuta; Kay Huebner; Carlo M Croce
Journal:  J Biol Chem       Date:  2008-03-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.